"Garbage in, garbage out", or, "give me enough degrees of freedom and I can fit an elephant". It's a reasonable retort given what's on display here. On the oth

"Garbage in, garbage out", or, "give me enough degrees of freedom and I can fit an elephant". It's a reasonable retort given what's on display here. On the other hand, if you do collect enough data in a particular domain to be able to call some interesting targets, it's straight-forward enough to validate the method. To presume generality (as the scientists probably do not, though as the article and every writeup I've seen here do) is surely foolhardy. As a side note, if the company wishes to pretty much sell to 'big pharma', why then do they publish these touchy-feely tech-crunch articles at all? Their website is designed for all those web-2.0 ideals of retaining customers and click-through and responsiveness, etc. But I doubt Roche cares about any of those things...